Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP-TEAD Protein-Protein Interaction Inhibitors

被引:11
|
作者
Sellner, Holger [1 ]
Chapeau, Emilie [2 ]
Furet, Pascal [1 ]
Voegtle, Markus [1 ]
Salem, Bahaa [1 ]
Le Douget, Mickael [1 ]
Bordas, Vincent [1 ]
Groell, Jean-Marc [1 ]
Le Goff, Anne-Laure [1 ]
Rouzet, Christine [1 ]
Wietlisbach, Thomas [1 ]
Zimmermann, Thomas [1 ]
McKenna, Joseph [1 ]
Brocklehurst, Cara E. E. [1 ]
Chene, Patrick [2 ]
Wartmann, Markus [2 ]
Scheufler, Clemens [3 ]
Kallen, Joerg [3 ]
Williams, Gareth [4 ]
Harlfinger, Stephanie [4 ]
Traebert, Martin [5 ]
Dumotier, Berengere M. [5 ]
Schmelzle, Tobias [2 ]
Soldermann, Nicolas [1 ]
机构
[1] Novartis Inst Biomed Res, Global Discovery Chem, CH-4002 Basel, Switzerland
[2] Novartis Inst Biomed Res, Oncol Drug Discovery, CH-4002 Basel, Switzerland
[3] Novartis Inst Biomed Res, Chem Biol & Therapeut, CH-4002 Basel, Switzerland
[4] Novartis Inst Biomed Res, Pharmacokinet Sci, CH-4002 Basel, Switzerland
[5] Novartis Inst Biomed Res, Preclin Safety, CH-4002 Basel, Switzerland
关键词
TEAD; YAP; PPI inhibitors; multi-parameter optimization; in vivo efficacy; HIPPO PATHWAY;
D O I
10.1002/cmdc.202300051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of the YAP-TEAD protein-protein interaction constitutes a promising therapeutic approach for the treatment of cancers linked to the dysregulation of the Hippo signaling pathway. The identification of a class of small molecules which potently inhibit the YAP-TEAD interaction by binding tightly to the O-loop pocket of TEAD has previously been communicated. This report details the further multi-parameter optimization of this class of compounds resulting in advanced analogs combining nanomolar cellular potency with a balanced ADME and off-target profile, and efficacy of these compounds in tumor bearing mice is demonstrated for the first time.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Toward the Discovery of a Novel Class of YAP-TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP-TEAD Protein-Protein Interface
    Gibault, Floriane
    Coevoet, Mathilde
    Sturbaut, Manon
    Farce, Amaury
    Renault, Nicolas
    Allemand, Frederic
    Guichou, Jean-Francois
    Drucbert, Anne-Sophie
    Foulon, Catherine
    Magnez, Romain
    Thuru, Xavier
    Corvaisier, Matthieu
    Huet, Guillemette
    Chavatte, Philippe
    Melnyk, Patricia
    Bailly, Fabrice
    Cotelle, Philippe
    CANCERS, 2018, 10 (05)
  • [2] Discovery of YAP-TEAD protein-protein interaction (PPI) inhibitors for cancer therapy
    Soude, Anne
    Barth, Martine
    Bocart, Stephanie
    Thoreau, Frederic
    Masson, Philippe
    Braccini, Isabelle
    Montalbetti, Christian
    Brogue, Pierre
    Fromond, Claudia
    CANCER RESEARCH, 2016, 76
  • [3] Discovery of YAP-TEAD protein-protein interaction inhibitors (PPI) for treating malignant pleural mesothelioma (MPM).
    Soude, Anne
    Barth, Martine
    Luccarini, Jean-Michel
    Delaporte, Severine
    Chirade, Florence
    Valaire, Christelle
    Boulay, Aude
    Cheret, Genevieve
    Dorchie, Marie
    Estivalet, Celine
    Tuya-Boustugue, Pascale
    Tranchand, Robin
    Jean, Didier
    Quetel, Lisa
    Assie, Jean-Baptiste
    Konstantinova, Irena
    Junien, Jean-Louis
    Broqua, Pierre
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 49 - 49
  • [4] Identification of small molecule Pan-TEAD inhibitors disrupting YAP-TEAD protein-protein interaction and targeting gastric cancer cells
    Kumar, Ramesh
    Toh, Joel
    Thian, Joanne
    Mohideen, Noorul Farzana
    Sun, Jialin
    Chakraborty, Sayan
    Gunaratne, Jayantha
    Hong, Wanjin
    CANCER RESEARCH, 2024, 84 (07)
  • [5] Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3
    Zhou, Wei
    Li, Yiping
    Song, Jinhua
    Li, Chenglong
    ANALYTICAL BIOCHEMISTRY, 2019, 586
  • [6] A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction
    Park, J. S.
    Shin, Y. K.
    Hong, E.
    Park, Y. H.
    Um, J.
    Lee, D.
    Kwon, H. S.
    Issabayeva, G.
    Kang, O. Y.
    Lim, B. H.
    Park, S. J.
    Lim, H. J.
    Jeung, H. C.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S37 - S37
  • [7] Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction
    Zhang, Zhisen
    Lin, Zhaohu
    Zhou, Zheng
    Shen, Hong C.
    Yan, S. Frank
    Mayweg, Alexander V.
    Xu, Zhiheng
    Qin, Ning
    Wong, Jason C.
    Zhang, Zhenshan
    Rong, Yiping
    Fry, David C.
    Hu, Taishan
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (09): : 993 - 998
  • [8] Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence
    Furet, Pascal
    Salem, Bahaa
    Mesrouze, Yannick
    Schmelzle, Tobias
    Lewis, Ian
    Kallen, Joerg
    Chene, Patrick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2316 - 2319
  • [9] Development of a fluorescence polarization assay for the identification and evaluation of inhibitors at the Ω-loop region of the YAP-TEAD protein-protein interface (PPI)
    Zhou, Wei
    Li, Yiping
    Song, Jinhua
    Li, Chenglong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [10] Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery
    Kim, Jongwan
    Lim, Hocheol
    Moon, Sungho
    Cho, Seon Yeon
    Kim, Minhye
    Park, Jae Hyung
    Park, Hyun Woo
    No, Kyoung Tai
    CANCERS, 2021, 13 (16)